Please login to the form below

Not currently logged in
Email:
Password:

Global growth for pharma market

A leading financial analyst specialising in pharmaceutical sales data has revealed that the global prescription drugs market grew by 6.4 per cent in 2007.

A leading financial analyst specialising in pharmaceutical sales data has revealed that the global prescription drugs market grew by 6.4 per cent in 2007.

Market intelligence provider, IMS Health announced on April 16 that the global prescription market increased by $178m over a five-year period to an estimated total of $712m. But the US market, which accounts for 45.9 per cent of worldwide pharmaceutical sales (almost $304.5bn), recorded a downturn in its market growth rate.

IMS Health said: "The United States is still the largest single market at $286.5bn. However, it contributed only 2.5 per cent of the total growth to the global market in 2007 - the lowest-ever level of contribution."

France, Germany, the UK, Italy and Spain (the five major EU markets) experienced aggregate growth of 4.8 per cent, expanding to $140bn.

16th April 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics